首页 | 本学科首页   官方微博 | 高级检索  
     


Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin,a DPP-4 inhibitor,in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea
Authors:Yoshimasa Aso  Noriyuki Ozeki  Tomoko Terasawa  Rika Naruse  Kenji Hara  Mariko Suetsugu  Kohzo Takebayashi  Mitsuei Shibazaki  Kohsuke Haruki  Kimio Morita  Toshihiko Inukai
Affiliation:1. Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Boston Medical Center, Boston, Massachusetts;2. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.;1. Dept of Medicine, University of Padua, Italy;2. Unit of Hepatobiliary Surgery and Liver Transplantation, University of Padua, Italy;3. Dept of Laboratory Medicine, Azienda Ospedaliera, Padua, Italy;4. Dept of Biomedical Sciences, University of Padua, Italy;5. Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
正在获取相似文献,请稍候...
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号